Found: 4
Select item for more details and to access through your institution.
Heterogeneity in Vaccinal Immunity to SARS-CoV-2 Can Be Addressed by a Personalized Booster Strategy.
- Published in:
- Vaccines, 2023, v. 11, n. 4, p. 806, doi. 10.3390/vaccines11040806
- By:
- Publication type:
- Article
At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron Variant.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.883612
- By:
- Publication type:
- Article
Highly Thermotolerant SARS-CoV-2 Vaccine Elicits Neutralising Antibodies against Delta and Omicron in Mice.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 4, p. N.PAG, doi. 10.3390/v14040800
- By:
- Publication type:
- Article
Tracking Co-Occurrence of N501Y, P681R, and Other Key Mutations in SARS-CoV-2 Spike for Surveillance.
- Published in:
- Zoonotic Diseases (2813-0227), 2022, v. 2, n. 3, p. 147, doi. 10.3390/zoonoticdis2030014
- By:
- Publication type:
- Article